ValueSet Para Hallazgos Clínicos de la CIE 11 para neoplasias - Repositorio de Reportes de Biopsias Oncológicas v0.3.2

This page is part of the Repositorio de Reportes de Biopsias Oncológicas (v0.3.2: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: ValueSet Para Hallazgos Clínicos de la CIE 11 para neoplasias

Official URL: https://interoperabilidad.minsal.cl/fhir/ig/r2bo/ValueSet/r2bo-hallazgos-clinicos-cie11-VS				Version: 0.3.2
Active as of 2026-09-14				Computable Name: HallazgosClinicosCIE11VS
Other Identifiers: OID:2.16.840.1.113883.2.22.40.8.48.7

Este ValueSet contiene los códigos de la CIE 11 para hallazgos clínicos de neoplasias, que son utilizados en la definición de perfiles de recursos FHIR para la interoperabilidad en salud.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Include codes fromhttp://id.who.int/icd/release/11/mms version Not Stated (use latest from terminology server) where concept descends from 1630407678 (Neoplasms) and classKind = category

Expansion

Expansion from tx.hl7chile.cl based on codesystem International Classification of Diseases, 11th Revision Mortality and Morbidity Statistics (MMS) version 2026-01-17

This value set has 1.247 codes in it. In order to keep the publication size manageable, only a selection (1.000 codes) of the whole set of codes is shown.

System	Code	Display (en)	JSON	XML
`http://id.who.int/icd/release/11/mms`	2A00	Primary neoplasms of brain
`http://id.who.int/icd/release/11/mms`	2A00.0	Gliomas of brain
`http://id.who.int/icd/release/11/mms`	2A00.00	Glioblastoma of brain
`http://id.who.int/icd/release/11/mms`	2A00.0Y	Other specified gliomas of brain
`http://id.who.int/icd/release/11/mms`	2A00.0Z	Gliomas of brain, unspecified
`http://id.who.int/icd/release/11/mms`	2A00.1	Embryonal tumours of brain
`http://id.who.int/icd/release/11/mms`	2A00.10	Medulloblastoma of brain
`http://id.who.int/icd/release/11/mms`	2A00.11	Central primitive neuroectodermal tumour
`http://id.who.int/icd/release/11/mms`	2A00.1Y	Other specified embryonal tumours of brain
`http://id.who.int/icd/release/11/mms`	2A00.1Z	Embryonal tumours of brain, unspecified
`http://id.who.int/icd/release/11/mms`	2A00.2	Tumours of neuroepithelial tissue of brain
`http://id.who.int/icd/release/11/mms`	2A00.20	Tumours of the pineal gland or pineal region
`http://id.who.int/icd/release/11/mms`	2A00.21	Mixed neuronal-glial tumours
`http://id.who.int/icd/release/11/mms`	2A00.22	Choroid plexus tumours
`http://id.who.int/icd/release/11/mms`	2A00.2Y	Other specified tumours of neuroepithelial tissue of brain
`http://id.who.int/icd/release/11/mms`	2A00.2Z	Tumours of neuroepithelial tissue of brain, unspecified
`http://id.who.int/icd/release/11/mms`	2A00.3	Central neurocytoma of brain
`http://id.who.int/icd/release/11/mms`	2A00.4	Astroblastoma of the brain
`http://id.who.int/icd/release/11/mms`	2A00.5	Primary neoplasm of brain of unknown or unspecified type
`http://id.who.int/icd/release/11/mms`	2A01	Primary neoplasms of meninges
`http://id.who.int/icd/release/11/mms`	2A01.0	Meningiomas
`http://id.who.int/icd/release/11/mms`	2A01.00	Primary malignant meningioma
`http://id.who.int/icd/release/11/mms`	2A01.0Y	Other specified meningiomas
`http://id.who.int/icd/release/11/mms`	2A01.0Z	Meningiomas, unspecified
`http://id.who.int/icd/release/11/mms`	2A01.1	Mesenchymal tumour of meninges
`http://id.who.int/icd/release/11/mms`	2A01.2	Primary neoplasm of meninges of unknown or unspecified type
`http://id.who.int/icd/release/11/mms`	2A02	Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system
`http://id.who.int/icd/release/11/mms`	2A02.0	Gliomas of spinal cord, cranial or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2A02.00	Glioblastoma of spinal cord, cranial or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2A02.0Y	Other specified gliomas of spinal cord, cranial or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2A02.0Z	Gliomas of spinal cord, cranial or paraspinal nerves, unspecified
`http://id.who.int/icd/release/11/mms`	2A02.1	Tumours of cranial or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2A02.10	Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2A02.11	Paraspinal neuroblastoma
`http://id.who.int/icd/release/11/mms`	2A02.12	Malignant neoplasm of the optic nerve
`http://id.who.int/icd/release/11/mms`	2A02.1Y	Other specified tumours of cranial or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2A02.1Z	Tumours of cranial or paraspinal nerves, unspecified
`http://id.who.int/icd/release/11/mms`	2A02.2	Primary neoplasm of spinal cord of unknown or unspecified type
`http://id.who.int/icd/release/11/mms`	2A02.3	Benign neoplasm of cranial nerves
`http://id.who.int/icd/release/11/mms`	2A02.4	Benign neoplasm of spinal cord
`http://id.who.int/icd/release/11/mms`	2A02.Z	Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system, unspecified
`http://id.who.int/icd/release/11/mms`	2A0Z	Other and unspecified neoplasms of brain or central nervous system
`http://id.who.int/icd/release/11/mms`	2A20	Non mast cell myeloproliferative neoplasms
`http://id.who.int/icd/release/11/mms`	2A20.0	Chronic myelogenous leukaemia, BCR-ABL1-positive
`http://id.who.int/icd/release/11/mms`	2A20.00	Chronic myelogenous leukaemia with blast crisis
`http://id.who.int/icd/release/11/mms`	2A20.01	Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive
`http://id.who.int/icd/release/11/mms`	2A20.02	Chronic myelogenous leukaemia, t(9:22)(q34; q11)
`http://id.who.int/icd/release/11/mms`	2A20.03	Naegeli-type monocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A20.0Y	Other specified chronic myelogenous leukaemia, BCR-ABL1-positive
`http://id.who.int/icd/release/11/mms`	2A20.0Z	Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified
`http://id.who.int/icd/release/11/mms`	2A20.1	Chronic neutrophilic leukaemia
`http://id.who.int/icd/release/11/mms`	2A20.2	Primary myelofibrosis
`http://id.who.int/icd/release/11/mms`	2A20.3	Chronic eosinophilic leukaemia, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2A20.4	Polycythaemia vera
`http://id.who.int/icd/release/11/mms`	2A20.5	Non mast cell myeloproliferative neoplasm, unclassifiable
`http://id.who.int/icd/release/11/mms`	2A20.Y	Other specified non mast cell myeloproliferative neoplasms
`http://id.who.int/icd/release/11/mms`	2A20.Z	Non mast cell myeloproliferative neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2A21	Mastocytosis
`http://id.who.int/icd/release/11/mms`	2A21.0	Systemic mastocytosis
`http://id.who.int/icd/release/11/mms`	2A21.00	Mast cell leukaemia
`http://id.who.int/icd/release/11/mms`	2A21.0Y	Other specified systemic mastocytosis
`http://id.who.int/icd/release/11/mms`	2A21.0Z	Systemic mastocytosis, unspecified
`http://id.who.int/icd/release/11/mms`	2A21.1	Cutaneous mastocytosis
`http://id.who.int/icd/release/11/mms`	2A21.10	Urticaria pigmentosa
`http://id.who.int/icd/release/11/mms`	2A21.1Y	Other specified cutaneous mastocytosis
`http://id.who.int/icd/release/11/mms`	2A21.1Z	Cutaneous mastocytosis, unspecified
`http://id.who.int/icd/release/11/mms`	2A21.2	Mast cell sarcoma
`http://id.who.int/icd/release/11/mms`	2A21.3	Extracutaneous mastocytoma
`http://id.who.int/icd/release/11/mms`	2A21.Y	Other specified mastocytosis
`http://id.who.int/icd/release/11/mms`	2A21.Z	Mastocytosis, unspecified
`http://id.who.int/icd/release/11/mms`	2A2Y	Other specified myeloproliferative neoplasm
`http://id.who.int/icd/release/11/mms`	2A2Z	Myeloproliferative neoplasm, unspecified
`http://id.who.int/icd/release/11/mms`	2A30	Refractory anaemia
`http://id.who.int/icd/release/11/mms`	2A31	Refractory neutropaenia
`http://id.who.int/icd/release/11/mms`	2A32	Refractory thrombocytopenia
`http://id.who.int/icd/release/11/mms`	2A33	Refractory anaemia with ring sideroblasts
`http://id.who.int/icd/release/11/mms`	2A34	Refractory cytopenia with multi-lineage dysplasia
`http://id.who.int/icd/release/11/mms`	2A35	Refractory anaemia with excess of blasts
`http://id.who.int/icd/release/11/mms`	2A36	Myelodysplastic syndrome with isolated del(5q)
`http://id.who.int/icd/release/11/mms`	2A37	Myelodysplastic syndrome, unclassifiable
`http://id.who.int/icd/release/11/mms`	2A38	Refractory cytopenia of childhood
`http://id.who.int/icd/release/11/mms`	2A3Y	Other specified myelodysplastic syndromes
`http://id.who.int/icd/release/11/mms`	2A3Z	Myelodysplastic syndromes, unspecified
`http://id.who.int/icd/release/11/mms`	2A40	Chronic myelomonocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A41	Atypical chronic myeloid leukaemia, BCR-ABL1-negative
`http://id.who.int/icd/release/11/mms`	2A42	Juvenile myelomonocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A42.0	Juvenile myelomonocytic leukaemia in complete remission
`http://id.who.int/icd/release/11/mms`	2A42.Y	Other specified juvenile myelomonocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A42.Z	Juvenile myelomonocytic leukaemia, unspecified
`http://id.who.int/icd/release/11/mms`	2A43	Refractory anaemia with ring sideroblasts associated with marked thrombocytosis
`http://id.who.int/icd/release/11/mms`	2A44	Myeloproliferative and myelodysplastic disease, unclassifiable
`http://id.who.int/icd/release/11/mms`	2A4Y	Other specified myelodysplastic and myeloproliferative neoplasms
`http://id.who.int/icd/release/11/mms`	2A4Z	Myelodysplastic and myeloproliferative neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2A50	Myeloid or lymphoid neoplasm associated with PDGFRA rearrangement
`http://id.who.int/icd/release/11/mms`	2A51	Myeloid neoplasm associated with PDGFRB rearrangement
`http://id.who.int/icd/release/11/mms`	2A52	Myeloid or lymphoid neoplasms with FGFR1 abnormalities
`http://id.who.int/icd/release/11/mms`	2A5Z	Myeloid or lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified
`http://id.who.int/icd/release/11/mms`	2A60	Acute myeloid leukaemias and related precursor neoplasms
`http://id.who.int/icd/release/11/mms`	2A60.0	Acute myeloid leukaemia with recurrent genetic abnormalities
`http://id.who.int/icd/release/11/mms`	2A60.1	Acute myeloid leukaemia with myelodysplasia-related changes
`http://id.who.int/icd/release/11/mms`	2A60.2	Therapy-related myeloid neoplasms
`http://id.who.int/icd/release/11/mms`	2A60.20	Therapy related acute myeloid leukaemia or myelodysplastic syndrome
`http://id.who.int/icd/release/11/mms`	2A60.2Y	Other specified therapy-related myeloid neoplasms
`http://id.who.int/icd/release/11/mms`	2A60.2Z	Therapy-related myeloid neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2A60.3	Acute myeloid leukaemia, not elsewhere classified by criteria of other types
`http://id.who.int/icd/release/11/mms`	2A60.30	Acute myeloid leukaemia with minimal differentiation
`http://id.who.int/icd/release/11/mms`	2A60.31	Acute myeloid leukaemia without maturation
`http://id.who.int/icd/release/11/mms`	2A60.32	Acute myeloid leukaemia with maturation
`http://id.who.int/icd/release/11/mms`	2A60.33	Acute myelomonocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A60.34	Acute monoblastic or monocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A60.35	Acute erythroid leukaemia
`http://id.who.int/icd/release/11/mms`	2A60.36	Acute megakaryoblastic leukaemia
`http://id.who.int/icd/release/11/mms`	2A60.37	Acute basophilic leukaemia
`http://id.who.int/icd/release/11/mms`	2A60.38	Acute panmyelosis with myelofibrosis
`http://id.who.int/icd/release/11/mms`	2A60.39	Myeloid sarcoma
`http://id.who.int/icd/release/11/mms`	2A60.3Y	Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types
`http://id.who.int/icd/release/11/mms`	2A60.3Z	Acute myeloid leukaemia, unspecified
`http://id.who.int/icd/release/11/mms`	2A60.4	Myeloid proliferation associated with Down syndrome
`http://id.who.int/icd/release/11/mms`	2A60.40	Transient abnormal myelopoiesis
`http://id.who.int/icd/release/11/mms`	2A60.41	Myeloid leukaemia associated with Down syndrome
`http://id.who.int/icd/release/11/mms`	2A60.4Y	Other specified myeloid proliferation associated with Down syndrome
`http://id.who.int/icd/release/11/mms`	2A60.4Z	Myeloid proliferation associated with Down syndrome, unspecified
`http://id.who.int/icd/release/11/mms`	2A60.5	Blastic plasmacytoid dendritic cell neoplasm
`http://id.who.int/icd/release/11/mms`	2A60.Y	Other specified acute myeloid leukaemias and related precursor neoplasms
`http://id.who.int/icd/release/11/mms`	2A60.Z	Acute myeloid leukaemias and related precursor neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2A61	Acute leukaemias of ambiguous lineage
`http://id.who.int/icd/release/11/mms`	2A70	Precursor B-lymphoblastic neoplasms
`http://id.who.int/icd/release/11/mms`	2A70.0	B lymphoblastic leukaemia or lymphoma, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2A70.1	B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1
`http://id.who.int/icd/release/11/mms`	2A70.Y	Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities
`http://id.who.int/icd/release/11/mms`	2A71	Precursor T-lymphoblastic neoplasms
`http://id.who.int/icd/release/11/mms`	2A7Z	Precursor lymphoid neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2A80	Follicular lymphoma
`http://id.who.int/icd/release/11/mms`	2A80.0	Follicular lymphoma grade 1
`http://id.who.int/icd/release/11/mms`	2A80.1	Follicular lymphoma grade 2
`http://id.who.int/icd/release/11/mms`	2A80.2	Follicular lymphoma grade 3
`http://id.who.int/icd/release/11/mms`	2A80.3	Primary cutaneous follicle centre lymphoma
`http://id.who.int/icd/release/11/mms`	2A80.4	Paediatric type follicular lymphoma
`http://id.who.int/icd/release/11/mms`	2A80.5	Follicular lymphoma in situ
`http://id.who.int/icd/release/11/mms`	2A80.6	Follicular lymphoma of small intestine
`http://id.who.int/icd/release/11/mms`	2A80.Y	Other specified follicular lymphoma
`http://id.who.int/icd/release/11/mms`	2A80.Z	Follicular lymphoma, unspecified
`http://id.who.int/icd/release/11/mms`	2A81	Diffuse large B-cell lymphomas
`http://id.who.int/icd/release/11/mms`	2A81.0	Primary mediastinal large B-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A81.1	Intravascular large B-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A81.2	Plasmablastic lymphoma
`http://id.who.int/icd/release/11/mms`	2A81.3	Lymphomatoid granulomatosis
`http://id.who.int/icd/release/11/mms`	2A81.4	T-cell/histiocyte rich large B-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A81.5	Primary diffuse large B-cell lymphoma of central nervous system
`http://id.who.int/icd/release/11/mms`	2A81.6	Epstein-Barr Virus-positive diffuse large B-cell lymphoma of the elderly
`http://id.who.int/icd/release/11/mms`	2A81.7	Diffuse large B-cell lymphoma associated with chronic inflammation
`http://id.who.int/icd/release/11/mms`	2A81.8	ALK-positive large B-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A81.9	Primary effusion lymphoma
`http://id.who.int/icd/release/11/mms`	2A81.A	Primary cutaneous diffuse large B-cell lymphoma, leg type
`http://id.who.int/icd/release/11/mms`	2A81.Y	Other specified diffuse large B-cell lymphomas
`http://id.who.int/icd/release/11/mms`	2A81.Z	Diffuse large B-cell lymphoma, not otherwise specified
`http://id.who.int/icd/release/11/mms`	2A82	Mature B-cell neoplasm with leukaemic behaviour
`http://id.who.int/icd/release/11/mms`	2A82.0	Chronic lymphocytic leukaemia or small lymphocytic lymphoma
`http://id.who.int/icd/release/11/mms`	2A82.00	Chronic lymphocytic leukaemia of B-cell type
`http://id.who.int/icd/release/11/mms`	2A82.0Y	Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma
`http://id.who.int/icd/release/11/mms`	2A82.0Z	Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified
`http://id.who.int/icd/release/11/mms`	2A82.1	B-cell prolymphocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A82.10	B-cell prolymphocytic leukaemia in complete remission
`http://id.who.int/icd/release/11/mms`	2A82.1Y	Other specified b-cell prolymphocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A82.1Z	B-cell prolymphocytic leukaemia, unspecified
`http://id.who.int/icd/release/11/mms`	2A82.2	Hairy-cell leukaemia
`http://id.who.int/icd/release/11/mms`	2A82.3	Splenic B-cell lymphoma or leukaemia, unclassifiable
`http://id.who.int/icd/release/11/mms`	2A82.Y	Other specified mature B-cell neoplasm with leukaemic behaviour
`http://id.who.int/icd/release/11/mms`	2A82.Z	Mature B-cell neoplasm with leukaemic behaviour, unspecified
`http://id.who.int/icd/release/11/mms`	2A83	Plasma cell neoplasms
`http://id.who.int/icd/release/11/mms`	2A83.0	Monoclonal gammopathy of undetermined significance
`http://id.who.int/icd/release/11/mms`	2A83.1	Plasma cell myeloma
`http://id.who.int/icd/release/11/mms`	2A83.2	Solitary plasmacytoma
`http://id.who.int/icd/release/11/mms`	2A83.3	Extraosseous plasmacytoma
`http://id.who.int/icd/release/11/mms`	2A83.4	Plasma cell leukaemia
`http://id.who.int/icd/release/11/mms`	2A83.5	Monoclonal immunoglobulin deposition disease
`http://id.who.int/icd/release/11/mms`	2A83.50	Heavy chain deposition disease
`http://id.who.int/icd/release/11/mms`	2A83.51	Light and heavy chain deposition disease
`http://id.who.int/icd/release/11/mms`	2A83.52	Light chain deposition disease
`http://id.who.int/icd/release/11/mms`	2A83.Y	Other specified plasma cell neoplasms
`http://id.who.int/icd/release/11/mms`	2A83.Z	Plasma cell neoplasm, unspecified
`http://id.who.int/icd/release/11/mms`	2A84	Heavy chain diseases or malignant immunoproliferative diseases
`http://id.who.int/icd/release/11/mms`	2A84.0	Alpha heavy chain disease
`http://id.who.int/icd/release/11/mms`	2A84.1	Gamma heavy chain disease
`http://id.who.int/icd/release/11/mms`	2A84.2	Mu heavy chain disease
`http://id.who.int/icd/release/11/mms`	2A84.Y	Other specified malignant immunoproliferative diseases
`http://id.who.int/icd/release/11/mms`	2A84.Z	Heavy chain diseases, unspecified
`http://id.who.int/icd/release/11/mms`	2A85	Other specified mature B-cell neoplasms or lymphoma
`http://id.who.int/icd/release/11/mms`	2A85.0	Nodal marginal zone lymphoma
`http://id.who.int/icd/release/11/mms`	2A85.1	Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach
`http://id.who.int/icd/release/11/mms`	2A85.2	Extranodal marginal zone B-cell lymphoma, primary site skin
`http://id.who.int/icd/release/11/mms`	2A85.3	Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin
`http://id.who.int/icd/release/11/mms`	2A85.4	Lymphoplasmacytic lymphoma
`http://id.who.int/icd/release/11/mms`	2A85.5	Mantle cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A85.6	Burkitt lymphoma including Burkitt leukaemia
`http://id.who.int/icd/release/11/mms`	2A85.Y	Further specified mature B-cell neoplasms or lymphoma
`http://id.who.int/icd/release/11/mms`	2A86	B-cell lymphoma, mixed features
`http://id.who.int/icd/release/11/mms`	2A86.0	Malignant lymphoma of B cell type, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2A86.1	B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A86.2	B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A86.Y	Other specified B-cell lymphoma, mixed features
`http://id.who.int/icd/release/11/mms`	2A86.Z	B-cell lymphoma, mixed features, unspecified
`http://id.who.int/icd/release/11/mms`	2A8Z	Mature B-cell neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2A90	Mature T-cell lymphoma, specified types, nodal or systemic
`http://id.who.int/icd/release/11/mms`	2A90.0	T-cell prolymphocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A90.1	T-cell large granular lymphocytic leukaemia
`http://id.who.int/icd/release/11/mms`	2A90.2	Chronic lymphoproliferative disorders of NK-cells
`http://id.who.int/icd/release/11/mms`	2A90.3	Aggressive NK cell leukaemia
`http://id.who.int/icd/release/11/mms`	2A90.4	Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood
`http://id.who.int/icd/release/11/mms`	2A90.5	Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated
`http://id.who.int/icd/release/11/mms`	2A90.6	Extranodal NK/T-cell lymphoma, nasal type
`http://id.who.int/icd/release/11/mms`	2A90.7	Enteropathy associated T-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A90.8	Hepatosplenic T-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A90.9	Angioimmunoblastic T-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2A90.A	Anaplastic large cell lymphoma, ALK-positive
`http://id.who.int/icd/release/11/mms`	2A90.B	Anaplastic large cell lymphoma, ALK-negative
`http://id.who.int/icd/release/11/mms`	2A90.C	Peripheral T-cell lymphoma, not otherwise specified
`http://id.who.int/icd/release/11/mms`	2B00	Subcutaneous panniculitis-like T-cell lymphoma
`http://id.who.int/icd/release/11/mms`	2B01	Mycosis fungoides
`http://id.who.int/icd/release/11/mms`	2B02	Sézary syndrome
`http://id.who.int/icd/release/11/mms`	2B03	Primary cutaneous CD30-positive T-cell lymphoproliferative disorders
`http://id.who.int/icd/release/11/mms`	2B03.0	Primary cutaneous CD30-positive anaplastic large cell lymphoma
`http://id.who.int/icd/release/11/mms`	2B03.1	Lymphomatoid papulosis
`http://id.who.int/icd/release/11/mms`	2B0Y	Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders
`http://id.who.int/icd/release/11/mms`	2B0Z	Primary cutaneous T-cell lymphoma of undetermined or unspecified type
`http://id.who.int/icd/release/11/mms`	2B2Y	Other specified mature T-cell or NK-cell neoplasms
`http://id.who.int/icd/release/11/mms`	2B2Z	Mature T-cell or NK-cell neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2B30	Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.0	Nodular lymphocyte predominant Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.1	Classical Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.10	Nodular sclerosis classical Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.11	Lymphocyte-rich classical Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.12	Mixed cellularity classical Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.13	Lymphocyte depleted classical Hodgkin lymphoma
`http://id.who.int/icd/release/11/mms`	2B30.1Z	Classical Hodgkin lymphoma, unspecified
`http://id.who.int/icd/release/11/mms`	2B30.Z	Hodgkin lymphoma, unspecified
`http://id.who.int/icd/release/11/mms`	2B31	Histiocytic or dendritic cell neoplasms
`http://id.who.int/icd/release/11/mms`	2B31.0	Juvenile xanthogranuloma
`http://id.who.int/icd/release/11/mms`	2B31.1	Histiocytic sarcoma
`http://id.who.int/icd/release/11/mms`	2B31.2	Langerhans cell histiocytosis
`http://id.who.int/icd/release/11/mms`	2B31.20	Langerhans cell histiocytosis involving the skin
`http://id.who.int/icd/release/11/mms`	2B31.2Y	Other specified Langerhans cell histiocytosis
`http://id.who.int/icd/release/11/mms`	2B31.2Z	Langerhans cell histiocytosis, unspecified
`http://id.who.int/icd/release/11/mms`	2B31.3	Langerhans cell sarcoma
`http://id.who.int/icd/release/11/mms`	2B31.4	Interdigitating dendritic cell sarcoma
`http://id.who.int/icd/release/11/mms`	2B31.5	Follicular dendritic cell sarcoma
`http://id.who.int/icd/release/11/mms`	2B31.6	Indeterminate cell histiocytosis
`http://id.who.int/icd/release/11/mms`	2B31.7	Fibroblastic reticular cell tumour
`http://id.who.int/icd/release/11/mms`	2B31.Y	Other specified histiocytic or dendritic cell neoplasms
`http://id.who.int/icd/release/11/mms`	2B31.Z	Histiocytic or dendritic cell neoplasms, unspecified
`http://id.who.int/icd/release/11/mms`	2B32	Immunodeficiency-associated lymphoproliferative disorders
`http://id.who.int/icd/release/11/mms`	2B32.0	Post-transplant lymphoproliferative disorder, early lesion
`http://id.who.int/icd/release/11/mms`	2B32.1	Reactive plasmacytic hyperplasia
`http://id.who.int/icd/release/11/mms`	2B32.2	Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like
`http://id.who.int/icd/release/11/mms`	2B32.3	Polymorphic post-transplant lymphoproliferative disorder
`http://id.who.int/icd/release/11/mms`	2B32.Y	Other specified immunodeficiency-associated lymphoproliferative disorders
`http://id.who.int/icd/release/11/mms`	2B32.Z	Immunodeficiency-associated lymphoproliferative disorders, unspecified
`http://id.who.int/icd/release/11/mms`	2B33	Malignant haematopoietic neoplasms without further specification
`http://id.who.int/icd/release/11/mms`	2B33.0	Acute leukaemia, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2B33.1	Myeloid leukaemia
`http://id.who.int/icd/release/11/mms`	2B33.2	Chronic myeloid leukaemia, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2B33.3	Lymphoid leukaemia, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2B33.4	Leukaemia, unspecified
`http://id.who.int/icd/release/11/mms`	2B33.5	Malignant lymphoma, not elsewhere classified
`http://id.who.int/icd/release/11/mms`	2B33.Y	Other malignant haematopoietic neoplasms without further specification
`http://id.who.int/icd/release/11/mms`	2B3Z	Neoplasms of haematopoietic or lymphoid tissues, unspecified
`http://id.who.int/icd/release/11/mms`	2B50	Chondrosarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B50.0	Chondrosarcoma of bone or articular cartilage of limbs
`http://id.who.int/icd/release/11/mms`	2B50.1	Chondrosarcoma of bone or articular cartilage of pelvis
`http://id.who.int/icd/release/11/mms`	2B50.2	Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle
`http://id.who.int/icd/release/11/mms`	2B50.Y	Chondrosarcoma of bone or articular cartilage of other specified sites
`http://id.who.int/icd/release/11/mms`	2B50.Z	Chondrosarcoma of bone or articular cartilage of unspecified sites
`http://id.who.int/icd/release/11/mms`	2B51	Osteosarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B51.0	Osteosarcoma of bone or articular cartilage of jaw
`http://id.who.int/icd/release/11/mms`	2B51.1	Osteosarcoma of bone or articular cartilage of limbs
`http://id.who.int/icd/release/11/mms`	2B51.2	Osteosarcoma of bone or articular cartilage of pelvis
`http://id.who.int/icd/release/11/mms`	2B51.Y	Osteosarcoma of bone or articular cartilage of other specified sites
`http://id.who.int/icd/release/11/mms`	2B51.Z	Osteosarcoma of bone or articular cartilage of unspecified sites
`http://id.who.int/icd/release/11/mms`	2B52	Ewing sarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B52.0	Ewing sarcoma of bone or articular cartilage of limbs
`http://id.who.int/icd/release/11/mms`	2B52.1	Ewing sarcoma of bone or articular cartilage of pelvis
`http://id.who.int/icd/release/11/mms`	2B52.2	Ewing sarcoma of bone or articular cartilage of ribs
`http://id.who.int/icd/release/11/mms`	2B52.3	Ewing sarcoma of soft tissue
`http://id.who.int/icd/release/11/mms`	2B52.Y	Ewing sarcoma of bone or articular cartilage of other specified sites
`http://id.who.int/icd/release/11/mms`	2B52.Z	Ewing sarcoma of bone or articular cartilage of unspecified sites
`http://id.who.int/icd/release/11/mms`	2B53	Fibroblastic or myofibroblastic tumour, primary site
`http://id.who.int/icd/release/11/mms`	2B53.0	Myxofibrosarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B53.1	Fibroblastic or myofibroblastic tumour of skin
`http://id.who.int/icd/release/11/mms`	2B53.Y	Other specified fibroblastic or myofibroblastic tumour, primary site
`http://id.who.int/icd/release/11/mms`	2B53.Z	Fibroblastic or myofibroblastic tumour, primary site, unspecified
`http://id.who.int/icd/release/11/mms`	2B54	Undifferentiated pleomorphic sarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B54.0	Undifferentiated pleomorphic sarcoma of skin
`http://id.who.int/icd/release/11/mms`	2B54.1	Undifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum
`http://id.who.int/icd/release/11/mms`	2B54.Y	Undifferentiated pleomorphic sarcoma, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B54.Z	Undifferentiated pleomorphic sarcoma, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B55	Rhabdomyosarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B55.0	Rhabdomyosarcoma of the oral cavity or pharynx
`http://id.who.int/icd/release/11/mms`	2B55.1	Rhabdomyosarcoma of respiratory or intrathoracic organs
`http://id.who.int/icd/release/11/mms`	2B55.2	Rhabdomyosarcoma of male genital organs
`http://id.who.int/icd/release/11/mms`	2B55.Y	Rhabdomyosarcoma, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B55.Z	Rhabdomyosarcoma, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B56	Angiosarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B56.0	Angiosarcoma of heart
`http://id.who.int/icd/release/11/mms`	2B56.1	Angiosarcoma of skin
`http://id.who.int/icd/release/11/mms`	2B56.2	Angiosarcoma of breast
`http://id.who.int/icd/release/11/mms`	2B56.3	Angiosarcoma of liver
`http://id.who.int/icd/release/11/mms`	2B56.Y	Angiosarcoma, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B56.Z	Angiosarcoma, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B57	Kaposi sarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B57.0	Kaposi sarcoma of lung
`http://id.who.int/icd/release/11/mms`	2B57.1	Kaposi sarcoma of skin
`http://id.who.int/icd/release/11/mms`	2B57.2	Kaposi sarcoma of gastrointestinal sites
`http://id.who.int/icd/release/11/mms`	2B57.Y	Kaposi sarcoma of other specified primary sites
`http://id.who.int/icd/release/11/mms`	2B57.Z	Kaposi sarcoma of unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B58	Leiomyosarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B58.0	Leiomyosarcoma of retroperitoneum or peritoneum
`http://id.who.int/icd/release/11/mms`	2B58.1	Leiomyosarcoma of uterus
`http://id.who.int/icd/release/11/mms`	2B58.2	Leiomyosarcoma of stomach
`http://id.who.int/icd/release/11/mms`	2B58.Y	Leiomyosarcoma, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B58.Z	Leiomyosarcoma, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B59	Liposarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B59.0	Liposarcoma of soft tissue of limb
`http://id.who.int/icd/release/11/mms`	2B59.1	Liposarcoma of retroperitoneum or peritoneum
`http://id.who.int/icd/release/11/mms`	2B59.2	Liposarcoma of male genital organs
`http://id.who.int/icd/release/11/mms`	2B59.Y	Liposarcoma, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B59.Z	Liposarcoma, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B5A	Synovial sarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B5A.0	Synovial sarcoma of soft tissues of limb
`http://id.who.int/icd/release/11/mms`	2B5A.1	Synovial sarcoma of respiratory or intra-thoracic organs
`http://id.who.int/icd/release/11/mms`	2B5A.Y	Synovial sarcoma, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B5A.Z	Synovial sarcoma, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B5B	Gastrointestinal stromal tumour, primary site
`http://id.who.int/icd/release/11/mms`	2B5B.0	Gastrointestinal stromal tumour of stomach
`http://id.who.int/icd/release/11/mms`	2B5B.1	Gastrointestinal stromal tumour of small intestine
`http://id.who.int/icd/release/11/mms`	2B5B.Y	Gastrointestinal stromal tumour of other gastrointestinal sites
`http://id.who.int/icd/release/11/mms`	2B5B.Z	Gastrointestinal stromal tumour of unspecified gastrointestinal sites
`http://id.who.int/icd/release/11/mms`	2B5C	Endometrial stromal sarcoma, primary site
`http://id.who.int/icd/release/11/mms`	2B5D	Malignant mixed epithelial mesenchymal tumour, primary site
`http://id.who.int/icd/release/11/mms`	2B5D.0	Malignant mixed epithelial mesenchymal tumour of ovary
`http://id.who.int/icd/release/11/mms`	2B5D.1	Malignant mixed epithelial and mesenchymal tumour of corpus uteri
`http://id.who.int/icd/release/11/mms`	2B5D.Y	Malignant mixed epithelial mesenchymal tumour, other specified primary site
`http://id.who.int/icd/release/11/mms`	2B5D.Z	Malignant mixed epithelial mesenchymal tumour, unspecified primary site
`http://id.who.int/icd/release/11/mms`	2B5E	Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
`http://id.who.int/icd/release/11/mms`	2B5F	Sarcoma, not elsewhere classified, primary site
`http://id.who.int/icd/release/11/mms`	2B5F.0	Sarcoma, not elsewhere classified of uterus
`http://id.who.int/icd/release/11/mms`	2B5F.1	Sarcoma, not elsewhere classified of retroperitoneum or peritoneum
`http://id.who.int/icd/release/11/mms`	2B5F.10	Myosarcomas of omentum
`http://id.who.int/icd/release/11/mms`	2B5F.1Y	Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum
`http://id.who.int/icd/release/11/mms`	2B5F.1Z	Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified
`http://id.who.int/icd/release/11/mms`	2B5F.2	Sarcoma, not elsewhere classified of other specified sites
`http://id.who.int/icd/release/11/mms`	2B5F.3	Sarcoma, not elsewhere classified, primary site unknown
`http://id.who.int/icd/release/11/mms`	2B5G	Myosarcoma of uterus, part not specified
`http://id.who.int/icd/release/11/mms`	2B5H	Well differentiated lipomatous tumour, primary site
`http://id.who.int/icd/release/11/mms`	2B5J	Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
`http://id.who.int/icd/release/11/mms`	2B5K	Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
`http://id.who.int/icd/release/11/mms`	2B5Y	Other specified malignant mesenchymal neoplasms
`http://id.who.int/icd/release/11/mms`	2B5Z	Malignant mesenchymal neoplasm of unspecified type
`http://id.who.int/icd/release/11/mms`	2B60	Malignant neoplasms of lip
`http://id.who.int/icd/release/11/mms`	2B60.0	Basal cell carcinoma of lip
`http://id.who.int/icd/release/11/mms`	2B60.1	Squamous cell carcinoma of lip
`http://id.who.int/icd/release/11/mms`	2B60.Y	Other specified malignant neoplasms of lip
`http://id.who.int/icd/release/11/mms`	2B60.Z	Malignant neoplasms of lip, unspecified
`http://id.who.int/icd/release/11/mms`	2B61	Malignant neoplasms of base of tongue
`http://id.who.int/icd/release/11/mms`	2B61.0	Squamous cell carcinoma of the base of the tongue
`http://id.who.int/icd/release/11/mms`	2B61.Y	Other specified malignant neoplasms of base of tongue
`http://id.who.int/icd/release/11/mms`	2B61.Z	Malignant neoplasms of base of tongue, unspecified
`http://id.who.int/icd/release/11/mms`	2B62	Malignant neoplasms of other or unspecified parts of tongue
`http://id.who.int/icd/release/11/mms`	2B62.0	Squamous cell carcinoma of other or unspecified parts of tongue
`http://id.who.int/icd/release/11/mms`	2B62.1	Malignant neoplasms of lingual tonsil
`http://id.who.int/icd/release/11/mms`	2B62.10	Squamous cell carcinoma of lingual tonsil
`http://id.who.int/icd/release/11/mms`	2B62.1Y	Other specified malignant neoplasms of lingual tonsil
`http://id.who.int/icd/release/11/mms`	2B62.1Z	Malignant neoplasms of lingual tonsil, unspecified
`http://id.who.int/icd/release/11/mms`	2B62.Y	Other specified malignant neoplasms of other or unspecified parts of tongue
`http://id.who.int/icd/release/11/mms`	2B62.Z	Malignant neoplasms of other or unspecified parts of tongue, unspecified
`http://id.who.int/icd/release/11/mms`	2B63	Malignant neoplasms of gum
`http://id.who.int/icd/release/11/mms`	2B63.0	Squamous cell carcinoma of gum
`http://id.who.int/icd/release/11/mms`	2B63.Y	Other specified malignant neoplasm of gum
`http://id.who.int/icd/release/11/mms`	2B63.Z	Malignant neoplasms of gum, unspecified
`http://id.who.int/icd/release/11/mms`	2B64	Malignant neoplasms of floor of mouth
`http://id.who.int/icd/release/11/mms`	2B64.0	Squamous cell carcinoma of floor of mouth
`http://id.who.int/icd/release/11/mms`	2B64.Y	Other specified malignant neoplasm of floor of mouth
`http://id.who.int/icd/release/11/mms`	2B64.Z	Malignant neoplasms of floor of mouth, unspecified
`http://id.who.int/icd/release/11/mms`	2B65	Malignant neoplasms of palate
`http://id.who.int/icd/release/11/mms`	2B65.0	Adenocarcinoma of palate
`http://id.who.int/icd/release/11/mms`	2B65.1	Squamous cell carcinoma of palate
`http://id.who.int/icd/release/11/mms`	2B65.Y	Other specified malignant neoplasm of palate
`http://id.who.int/icd/release/11/mms`	2B65.Z	Malignant neoplasms of palate, unspecified
`http://id.who.int/icd/release/11/mms`	2B66	Malignant neoplasms of other or unspecified parts of mouth
`http://id.who.int/icd/release/11/mms`	2B66.0	Squamous cell carcinoma of other or unspecified parts of mouth
`http://id.who.int/icd/release/11/mms`	2B66.Y	Other specified malignant neoplasms of other or unspecified parts of mouth
`http://id.who.int/icd/release/11/mms`	2B66.Z	Malignant neoplasms of other or unspecified parts of mouth, unspecified
`http://id.who.int/icd/release/11/mms`	2B67	Malignant neoplasms of parotid gland
`http://id.who.int/icd/release/11/mms`	2B67.0	Adenocarcinoma of parotid gland
`http://id.who.int/icd/release/11/mms`	2B67.1	Squamous cell carcinoma of parotid gland
`http://id.who.int/icd/release/11/mms`	2B67.Y	Other specified malignant neoplasms of parotid gland
`http://id.who.int/icd/release/11/mms`	2B67.Z	Malignant neoplasms of parotid gland, unspecified
`http://id.who.int/icd/release/11/mms`	2B68	Malignant neoplasms of submandibular or sublingual glands
`http://id.who.int/icd/release/11/mms`	2B68.0	Adenocarcinoma of submandibular or sublingual glands
`http://id.who.int/icd/release/11/mms`	2B68.1	Squamous cell carcinoma of submandibular or sublingual glands
`http://id.who.int/icd/release/11/mms`	2B68.2	Other specified malignant neoplasms of submandibular or sublingual glands
`http://id.who.int/icd/release/11/mms`	2B68.Z	Malignant neoplasms of submandibular or sublingual glands, unspecified
`http://id.who.int/icd/release/11/mms`	2B69	Malignant neoplasms of tonsil
`http://id.who.int/icd/release/11/mms`	2B69.0	Squamous cell carcinoma of tonsil
`http://id.who.int/icd/release/11/mms`	2B69.1	Other specified malignant neoplasms of tonsil
`http://id.who.int/icd/release/11/mms`	2B69.Z	Malignant neoplasms of tonsil, unspecified
`http://id.who.int/icd/release/11/mms`	2B6A	Malignant neoplasms of oropharynx
`http://id.who.int/icd/release/11/mms`	2B6A.0	Squamous cell carcinoma of oropharynx
`http://id.who.int/icd/release/11/mms`	2B6A.Y	Other specified malignant neoplasms of oropharynx
`http://id.who.int/icd/release/11/mms`	2B6A.Z	Malignant neoplasms of oropharynx, unspecified
`http://id.who.int/icd/release/11/mms`	2B6B	Malignant neoplasms of nasopharynx
`http://id.who.int/icd/release/11/mms`	2B6B.0	Squamous cell carcinoma of nasopharynx
`http://id.who.int/icd/release/11/mms`	2B6B.1	Malignant epithelial neoplasms of nasopharynx, unspecified type
`http://id.who.int/icd/release/11/mms`	2B6B.2	Malignant neoplasms of pharyngeal tonsil
`http://id.who.int/icd/release/11/mms`	2B6B.20	Squamous cell carcinoma of pharyngeal tonsil
`http://id.who.int/icd/release/11/mms`	2B6B.21	Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil
`http://id.who.int/icd/release/11/mms`	2B6B.2Y	Other specified malignant neoplasms of pharyngeal tonsil
`http://id.who.int/icd/release/11/mms`	2B6B.2Z	Malignant neoplasm of pharyngeal tonsil without mention of type
`http://id.who.int/icd/release/11/mms`	2B6B.Y	Other specified malignant neoplasms of nasopharynx
`http://id.who.int/icd/release/11/mms`	2B6B.Z	Malignant neoplasms of nasopharynx, unspecified
`http://id.who.int/icd/release/11/mms`	2B6C	Malignant neoplasms of piriform sinus
`http://id.who.int/icd/release/11/mms`	2B6C.0	Squamous cell carcinoma of piriform sinus
`http://id.who.int/icd/release/11/mms`	2B6C.Y	Other specified malignant neoplasms of piriform sinus
`http://id.who.int/icd/release/11/mms`	2B6C.Z	Malignant neoplasms of piriform sinus, unspecified
`http://id.who.int/icd/release/11/mms`	2B6D	Malignant neoplasms of hypopharynx
`http://id.who.int/icd/release/11/mms`	2B6D.0	Squamous cell carcinoma and variants of hypopharynx
`http://id.who.int/icd/release/11/mms`	2B6D.Y	Other specified malignant neoplasms of hypopharynx
`http://id.who.int/icd/release/11/mms`	2B6D.Z	Malignant neoplasms of hypopharynx, unspecified
`http://id.who.int/icd/release/11/mms`	2B6E	Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
`http://id.who.int/icd/release/11/mms`	2B6E.0	Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx
`http://id.who.int/icd/release/11/mms`	2B6E.Y	Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
`http://id.who.int/icd/release/11/mms`	2B6E.Z	Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified
`http://id.who.int/icd/release/11/mms`	2B70	Malignant neoplasms of oesophagus
`http://id.who.int/icd/release/11/mms`	2B70.0	Adenocarcinoma of oesophagus
`http://id.who.int/icd/release/11/mms`	2B70.00	Barrett adenocarcinoma
`http://id.who.int/icd/release/11/mms`	2B70.0Y	Other specified adenocarcinoma of oesophagus
`http://id.who.int/icd/release/11/mms`	2B70.0Z	Adenocarcinoma of oesophagus, unspecified
`http://id.who.int/icd/release/11/mms`	2B70.1	Squamous cell carcinoma of oesophagus
`http://id.who.int/icd/release/11/mms`	2B70.Y	Other specified malignant neoplasms of oesophagus
`http://id.who.int/icd/release/11/mms`	2B70.Z	Malignant neoplasms of oesophagus, unspecified
`http://id.who.int/icd/release/11/mms`	2B71	Malignant neoplasms of oesophagogastric junction
`http://id.who.int/icd/release/11/mms`	2B71.0	Adenocarcinoma of oesophagogastric junction
`http://id.who.int/icd/release/11/mms`	2B71.Y	Other specified malignant neoplasm of oesophagogastric junction
`http://id.who.int/icd/release/11/mms`	2B71.Z	Malignant neoplasms of oesophagogastric junction, unspecified
`http://id.who.int/icd/release/11/mms`	2B72	Malignant neoplasms of stomach
`http://id.who.int/icd/release/11/mms`	2B72.0	Adenocarcinoma of stomach
`http://id.who.int/icd/release/11/mms`	2B72.1	Malignant neuroendocrine neoplasm of stomach
`http://id.who.int/icd/release/11/mms`	2B72.Y	Other specified malignant neoplasms of stomach
`http://id.who.int/icd/release/11/mms`	2B72.Z	Malignant neoplasms of stomach, unspecified
`http://id.who.int/icd/release/11/mms`	2B80	Malignant neoplasms of small intestine
`http://id.who.int/icd/release/11/mms`	2B80.0	Malignant neoplasms of duodenum
`http://id.who.int/icd/release/11/mms`	2B80.00	Adenocarcinoma of duodenum
`http://id.who.int/icd/release/11/mms`	2B80.01	Neuroendocrine neoplasm of duodenum
`http://id.who.int/icd/release/11/mms`	2B80.0Y	Other specified malignant neoplasms of the duodenum
`http://id.who.int/icd/release/11/mms`	2B80.0Z	Malignant neoplasms of duodenum, unspecified
`http://id.who.int/icd/release/11/mms`	2B80.1	Malignant neoplasms of jejunum or ileum
`http://id.who.int/icd/release/11/mms`	2B80.10	Adenocarcinoma of jejunum or ileum
`http://id.who.int/icd/release/11/mms`	2B80.11	Neuroendocrine neoplasms of jejunum or ileum
`http://id.who.int/icd/release/11/mms`	2B80.1Y	Other specified malignant neoplasms of jejunum or ileum
`http://id.who.int/icd/release/11/mms`	2B80.1Z	Malignant neoplasms of jejunum or ileum, unspecified
`http://id.who.int/icd/release/11/mms`	2B80.2	Malignant neoplasms of small intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B80.20	Adenocarcinoma of small intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B80.21	Neuroendocrine neoplasms of small intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B80.2Y	Other specified malignant neoplasms of small intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B80.Y	Other specified malignant neoplasms of small intestine
`http://id.who.int/icd/release/11/mms`	2B80.Z	Malignant neoplasms of small intestine, unspecified
`http://id.who.int/icd/release/11/mms`	2B81	Malignant neoplasms of appendix
`http://id.who.int/icd/release/11/mms`	2B81.0	Adenocarcinoma of appendix
`http://id.who.int/icd/release/11/mms`	2B81.00	Mucinous adenocarcinoma of appendix
`http://id.who.int/icd/release/11/mms`	2B81.2	Neuroendocrine neoplasms of appendix
`http://id.who.int/icd/release/11/mms`	2B81.Y	Other specified malignant neoplasms of appendix
`http://id.who.int/icd/release/11/mms`	2B81.Z	Malignant neoplasms of appendix, unspecified
`http://id.who.int/icd/release/11/mms`	2B90	Malignant neoplasms of colon
`http://id.who.int/icd/release/11/mms`	2B90.0	Malignant neoplasm of ascending colon or right flexure of colon
`http://id.who.int/icd/release/11/mms`	2B90.00	Adenocarcinoma of ascending colon or right flexure of colon
`http://id.who.int/icd/release/11/mms`	2B90.0Y	Other specified malignant neoplasm of ascending colon or right flexure of colon
`http://id.who.int/icd/release/11/mms`	2B90.0Z	Malignant neoplasm of ascending colon or right flexure of colon, unspecified
`http://id.who.int/icd/release/11/mms`	2B90.1	Malignant neoplasm of descending colon or splenic flexure of colon
`http://id.who.int/icd/release/11/mms`	2B90.10	Adenocarcinoma of descending colon or splenic flexure of colon
`http://id.who.int/icd/release/11/mms`	2B90.1Y	Other specified malignant neoplasm of descending colon or splenic flexure of colon
`http://id.who.int/icd/release/11/mms`	2B90.1Z	Malignant neoplasm of descending colon or splenic flexure of colon, unspecified
`http://id.who.int/icd/release/11/mms`	2B90.2	Malignant neoplasm of transverse colon
`http://id.who.int/icd/release/11/mms`	2B90.20	Adenocarcinoma of transverse colon
`http://id.who.int/icd/release/11/mms`	2B90.2Y	Other specified malignant neoplasm of transverse colon
`http://id.who.int/icd/release/11/mms`	2B90.2Z	Malignant neoplasm of transverse colon, unspecified
`http://id.who.int/icd/release/11/mms`	2B90.3	Malignant neoplasm of sigmoid colon
`http://id.who.int/icd/release/11/mms`	2B90.30	Adenocarcinoma of sigmoid colon
`http://id.who.int/icd/release/11/mms`	2B90.3Y	Other specified malignant neoplasm of sigmoid colon
`http://id.who.int/icd/release/11/mms`	2B90.3Z	Malignant neoplasm of sigmoid colon, unspecified
`http://id.who.int/icd/release/11/mms`	2B90.Y	Other specified malignant neoplasms of colon
`http://id.who.int/icd/release/11/mms`	2B90.Z	Malignant neoplasms of colon, unspecified
`http://id.who.int/icd/release/11/mms`	2B91	Malignant neoplasms of rectosigmoid junction
`http://id.who.int/icd/release/11/mms`	2B91.0	Adenocarcinoma of rectosigmoid junction
`http://id.who.int/icd/release/11/mms`	2B91.Y	Other specified malignant neoplasms of rectosigmoid junction
`http://id.who.int/icd/release/11/mms`	2B91.Z	Malignant neoplasms of rectosigmoid junction, unspecified
`http://id.who.int/icd/release/11/mms`	2B92	Malignant neoplasms of rectum
`http://id.who.int/icd/release/11/mms`	2B92.0	Adenocarcinomas of rectum
`http://id.who.int/icd/release/11/mms`	2B92.1	Neuroendocrine neoplasms of rectum
`http://id.who.int/icd/release/11/mms`	2B92.Y	Other specified malignant neoplasms of rectum
`http://id.who.int/icd/release/11/mms`	2B92.Z	Malignant neoplasms of rectum, unspecified
`http://id.who.int/icd/release/11/mms`	2B93	Malignant neoplasms of large intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B93.0	Adenocarcinoma of large intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B93.Y	Other specified malignant neoplasms of large intestine, site unspecified
`http://id.who.int/icd/release/11/mms`	2B93.Z	Malignant neoplasms of large intestine, site and type unspecified
`http://id.who.int/icd/release/11/mms`	2B9Y	Other specified malignant neoplasms of large intestine
`http://id.who.int/icd/release/11/mms`	2C00	Malignant neoplasms of anus or anal canal
`http://id.who.int/icd/release/11/mms`	2C00.0	Adenocarcinoma of anus or anal canal
`http://id.who.int/icd/release/11/mms`	2C00.1	Melanoma of anus or anal canal
`http://id.who.int/icd/release/11/mms`	2C00.2	Neuroendocrine neoplasm of anus or anal canal
`http://id.who.int/icd/release/11/mms`	2C00.3	Squamous cell carcinoma of anus or anal canal
`http://id.who.int/icd/release/11/mms`	2C00.Y	Other specified malignant neoplasms of anus or anal canal
`http://id.who.int/icd/release/11/mms`	2C00.Z	Malignant neoplasms of anus or anal canal, unspecified
`http://id.who.int/icd/release/11/mms`	2C0Y	Other specified malignant neoplasms of intestine
`http://id.who.int/icd/release/11/mms`	2C0Z	Malignant neoplasms of intestine, unspecified
`http://id.who.int/icd/release/11/mms`	2C10	Malignant neoplasm of pancreas
`http://id.who.int/icd/release/11/mms`	2C10.0	Adenocarcinoma of pancreas
`http://id.who.int/icd/release/11/mms`	2C10.1	Neuroendocrine neoplasms of pancreas
`http://id.who.int/icd/release/11/mms`	2C10.Y	Other specified malignant neoplasms of pancreas
`http://id.who.int/icd/release/11/mms`	2C10.Z	Malignant neoplasm of pancreas, unspecified
`http://id.who.int/icd/release/11/mms`	2C11	Malignant neoplasms of other or ill-defined digestive organs
`http://id.who.int/icd/release/11/mms`	2C11.0	Adenocarcinoma of other or ill-defined digestive organs
`http://id.who.int/icd/release/11/mms`	2C11.1	Mucinous carcinoma of other or ill-defined digestive organs
`http://id.who.int/icd/release/11/mms`	2C11.2	Other specified malignant neoplasms of other or ill-defined digestive organs
`http://id.who.int/icd/release/11/mms`	2C11.Z	Malignant neoplasms of other or ill-defined digestive organs, unspecified
`http://id.who.int/icd/release/11/mms`	2C12	Malignant neoplasms of liver or intrahepatic bile ducts
`http://id.who.int/icd/release/11/mms`	2C12.0	Malignant neoplasm of liver
`http://id.who.int/icd/release/11/mms`	2C12.00	Combined hepatocellular-cholangiocarcinoma
`http://id.who.int/icd/release/11/mms`	2C12.01	Hepatoblastoma
`http://id.who.int/icd/release/11/mms`	2C12.02	Hepatocellular carcinoma of liver
`http://id.who.int/icd/release/11/mms`	2C12.03	Mesothelial carcinoma of liver
`http://id.who.int/icd/release/11/mms`	2C12.0Y	Other specified malignant neoplasm of liver
`http://id.who.int/icd/release/11/mms`	2C12.0Z	Malignant neoplasm of liver, unspecified
`http://id.who.int/icd/release/11/mms`	2C12.1	Malignant neoplasm of intrahepatic bile ducts
`http://id.who.int/icd/release/11/mms`	2C12.10	Intrahepatic cholangiocarcinoma
`http://id.who.int/icd/release/11/mms`	2C12.1Y	Other specified malignant neoplasms of intrahepatic bile ducts
`http://id.who.int/icd/release/11/mms`	2C12.1Z	Malignant neoplasm of intrahepatic bile ducts, unspecified
`http://id.who.int/icd/release/11/mms`	2C13	Malignant neoplasms of gallbladder
`http://id.who.int/icd/release/11/mms`	2C13.0	Adenocarcinoma of the gallbladder
`http://id.who.int/icd/release/11/mms`	2C13.Y	Other specified malignant neoplasm of gallbladder
`http://id.who.int/icd/release/11/mms`	2C13.Z	Malignant neoplasms of gallbladder, unspecified
`http://id.who.int/icd/release/11/mms`	2C14	Malignant neoplasms of proximal biliary tract, cystic duct
`http://id.who.int/icd/release/11/mms`	2C14.0	Adenocarcinoma of proximal biliary tract, cystic duct
`http://id.who.int/icd/release/11/mms`	2C14.1	Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct
`http://id.who.int/icd/release/11/mms`	2C14.2	Neuroendocrine neoplasms of cystic duct
`http://id.who.int/icd/release/11/mms`	2C14.Y	Other specified malignant neoplasms of biliary tract, cystic duct
`http://id.who.int/icd/release/11/mms`	2C14.Z	Malignant neoplasms of proximal biliary tract, cystic duct, unspecified
`http://id.who.int/icd/release/11/mms`	2C15	Malignant neoplasms of biliary tract, distal bile duct
`http://id.who.int/icd/release/11/mms`	2C15.0	Adenocarcinoma of biliary tract, distal bile duct
`http://id.who.int/icd/release/11/mms`	2C15.1	Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct
`http://id.who.int/icd/release/11/mms`	2C15.2	Neuroendocrine neoplasms of distal bile duct
`http://id.who.int/icd/release/11/mms`	2C15.Y	Other specified malignant neoplasms of biliary tract, distal bile duct
`http://id.who.int/icd/release/11/mms`	2C15.Z	Malignant neoplasms of biliary tract, distal bile duct, unspecified
`http://id.who.int/icd/release/11/mms`	2C16	Malignant neoplasms of ampulla of Vater
`http://id.who.int/icd/release/11/mms`	2C16.0	Adenocarcinoma of ampulla of Vater
`http://id.who.int/icd/release/11/mms`	2C16.1	Neuroendocrine neoplasms of ampulla of Vater
`http://id.who.int/icd/release/11/mms`	2C16.Y	Other specified malignant neoplasms of ampulla of Vater
`http://id.who.int/icd/release/11/mms`	2C16.Z	Malignant neoplasms of ampulla of Vater, unspecified
`http://id.who.int/icd/release/11/mms`	2C17	Malignant neoplasms of other or unspecified parts of biliary tract
`http://id.who.int/icd/release/11/mms`	2C17.0	Adenocarcinoma of other or unspecified parts of biliary tract
`http://id.who.int/icd/release/11/mms`	2C17.1	Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract
`http://id.who.int/icd/release/11/mms`	2C17.2	Neuroendocrine neoplasms of other or unspecified parts of biliary tract
`http://id.who.int/icd/release/11/mms`	2C17.Y	Other specified malignant neoplasms of overlapping lesion of biliary tract
`http://id.who.int/icd/release/11/mms`	2C17.Z	Malignant neoplasms of other or unspecified parts of biliary tract, unspecified
`http://id.who.int/icd/release/11/mms`	2C18	Malignant neoplasms of perihilar bile duct
`http://id.who.int/icd/release/11/mms`	2C18.0	Hilar cholangiocarcinoma
`http://id.who.int/icd/release/11/mms`	2C18.1	Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct
`http://id.who.int/icd/release/11/mms`	2C18.2	Neuroendocrine neoplasm of perihilar bile duct
`http://id.who.int/icd/release/11/mms`	2C18.Y	Other specified malignant neoplasms of perihilar bile duct
`http://id.who.int/icd/release/11/mms`	2C18.Z	Malignant neoplasms of perihilar bile duct, unspecified
`http://id.who.int/icd/release/11/mms`	2C1Z	Malignant neoplasms of digestive organs, unspecified
`http://id.who.int/icd/release/11/mms`	2C20	Malignant neoplasms of nasal cavity
`http://id.who.int/icd/release/11/mms`	2C20.0	Adenocarcinoma of nasal cavity
`http://id.who.int/icd/release/11/mms`	2C20.1	Malignant neuroepitheliomatous neoplasm of nasal cavity
`http://id.who.int/icd/release/11/mms`	2C20.2	Melanoma of nasal cavity
`http://id.who.int/icd/release/11/mms`	2C20.3	Olfactory neuroblastoma
`http://id.who.int/icd/release/11/mms`	2C20.4	Squamous cell carcinoma of nasal cavity
`http://id.who.int/icd/release/11/mms`	2C20.Y	Other specified malignant neoplasm of nasal cavity
`http://id.who.int/icd/release/11/mms`	2C20.Z	Malignant neoplasms of nasal cavity, unspecified
`http://id.who.int/icd/release/11/mms`	2C21	Malignant neoplasms of middle ear
`http://id.who.int/icd/release/11/mms`	2C21.0	Adenocarcinoma of middle ear
`http://id.who.int/icd/release/11/mms`	2C21.1	Squamous cell carcinoma of middle ear
`http://id.who.int/icd/release/11/mms`	2C21.2	Unspecified malignant epithelial neoplasm of middle ear
`http://id.who.int/icd/release/11/mms`	2C21.Y	Other specified malignant neoplasm of middle ear
`http://id.who.int/icd/release/11/mms`	2C21.Z	Malignant neoplasms of middle ear, unspecified
`http://id.who.int/icd/release/11/mms`	2C22	Malignant neoplasms of accessory sinuses
`http://id.who.int/icd/release/11/mms`	2C22.0	Adenocarcinoma of accessory sinuses
`http://id.who.int/icd/release/11/mms`	2C22.1	Squamous cell carcinoma of accessory sinuses
`http://id.who.int/icd/release/11/mms`	2C22.10	Squamous cell carcinoma of sphenoidal sinus
`http://id.who.int/icd/release/11/mms`	2C22.1Y	Squamous cell carcinoma of other specified accessory sinuses
`http://id.who.int/icd/release/11/mms`	2C22.2	Malignant epithelial neoplasms of accessory sinuses, unspecified type
`http://id.who.int/icd/release/11/mms`	2C22.3	Melanomas of accessory sinuses
`http://id.who.int/icd/release/11/mms`	2C22.Y	Other specified malignant neoplasms of accessory sinuses
`http://id.who.int/icd/release/11/mms`	2C22.Z	Malignant neoplasms of accessory sinuses, unspecified
`http://id.who.int/icd/release/11/mms`	2C23	Malignant neoplasms of larynx
`http://id.who.int/icd/release/11/mms`	2C23.1	Malignant neoplasms of glottis of larynx
`http://id.who.int/icd/release/11/mms`	2C23.10	Squamous cell carcinoma of larynx, glottis
`http://id.who.int/icd/release/11/mms`	2C23.1Y	Other specified malignant neoplasms of larynx, glottis
`http://id.who.int/icd/release/11/mms`	2C23.1Z	Malignant neoplasms of glottis of larynx, unspecified
`http://id.who.int/icd/release/11/mms`	2C23.2	Malignant neoplasms of supraglottis of larynx
`http://id.who.int/icd/release/11/mms`	2C23.20	Squamous cell carcinoma of larynx, supraglottis
`http://id.who.int/icd/release/11/mms`	2C23.2Y	Other specified malignant neoplasms of larynx, supraglottis
`http://id.who.int/icd/release/11/mms`	2C23.2Z	Malignant neoplasms of supraglottis of larynx, unspecified
`http://id.who.int/icd/release/11/mms`	2C23.3	Malignant neoplasms of subglottis of larynx
`http://id.who.int/icd/release/11/mms`	2C23.30	Squamous cell carcinoma of larynx, subglottis
`http://id.who.int/icd/release/11/mms`	2C23.31	Adenocarcinoma of larynx, subglottis
`http://id.who.int/icd/release/11/mms`	2C23.3Y	Other specified malignant neoplasms of subglottis of larynx
`http://id.who.int/icd/release/11/mms`	2C23.3Z	Malignant neoplasms of subglottis of larynx, unspecified
`http://id.who.int/icd/release/11/mms`	2C23.4	Malignant neoplasm of laryngeal cartilage
`http://id.who.int/icd/release/11/mms`	2C23.5	Malignant neoplasm of overlapping lesion of larynx
`http://id.who.int/icd/release/11/mms`	2C23.Z	Malignant neoplasms of larynx, unspecified
`http://id.who.int/icd/release/11/mms`	2C24	Malignant neoplasms of trachea
`http://id.who.int/icd/release/11/mms`	2C24.0	Adenocarcinoma of trachea
`http://id.who.int/icd/release/11/mms`	2C24.1	Squamous cell carcinoma of trachea
`http://id.who.int/icd/release/11/mms`	2C24.2	Malignant epithelial neoplasms of trachea, unspecified type
`http://id.who.int/icd/release/11/mms`	2C24.Y	Other specified malignant neoplasms of trachea
`http://id.who.int/icd/release/11/mms`	2C24.Z	Malignant neoplasms of trachea, unspecified
`http://id.who.int/icd/release/11/mms`	2C25	Malignant neoplasms of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.0	Adenocarcinoma of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.1	Small cell carcinoma of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.2	Squamous cell carcinoma of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.3	Large cell carcinoma of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.4	Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.5	Unspecified malignant epithelial neoplasm of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.Y	Other specified malignant neoplasms of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2C25.Z	Malignant neoplasms of bronchus or lung, unspecified
`http://id.who.int/icd/release/11/mms`	2C26	Malignant neoplasms of the pleura
`http://id.who.int/icd/release/11/mms`	2C26.0	Mesothelioma of pleura
`http://id.who.int/icd/release/11/mms`	2C26.Y	Other specified malignant neoplasms of the pleura
`http://id.who.int/icd/release/11/mms`	2C26.Z	Malignant neoplasms of the pleura, unspecified
`http://id.who.int/icd/release/11/mms`	2C27	Malignant neoplasms of thymus
`http://id.who.int/icd/release/11/mms`	2C27.0	Carcinoma of thymus
`http://id.who.int/icd/release/11/mms`	2C27.1	Carcinoid tumour or other neuroendocrine neoplasms of thymus
`http://id.who.int/icd/release/11/mms`	2C27.2	Thymoma
`http://id.who.int/icd/release/11/mms`	2C27.Y	Other specified malignant neoplasms of thymus
`http://id.who.int/icd/release/11/mms`	2C27.Z	Malignant neoplasms of thymus, unspecified
`http://id.who.int/icd/release/11/mms`	2C28	Malignant neoplasms of heart or mediastinum
`http://id.who.int/icd/release/11/mms`	2C28.0	Malignant germ cell neoplasms of heart or mediastinum
`http://id.who.int/icd/release/11/mms`	2C28.1	Other specified malignant neoplasms of heart or mediastinum
`http://id.who.int/icd/release/11/mms`	2C28.Z	Malignant neoplasms of heart or mediastinum, unspecified
`http://id.who.int/icd/release/11/mms`	2C29	Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
`http://id.who.int/icd/release/11/mms`	2C29.0	Squamous cell carcinomas of other and ill-defined sites in the respiratory system or intrathoracic organs
`http://id.who.int/icd/release/11/mms`	2C29.1	Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs
`http://id.who.int/icd/release/11/mms`	2C29.Z	Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified
`http://id.who.int/icd/release/11/mms`	2C30	Melanoma of skin
`http://id.who.int/icd/release/11/mms`	2C30.0	Superficial spreading melanoma, primary
`http://id.who.int/icd/release/11/mms`	2C30.1	Nodular melanoma, primary
`http://id.who.int/icd/release/11/mms`	2C30.2	Lentigo maligna melanoma, primary
`http://id.who.int/icd/release/11/mms`	2C30.3	Acral lentiginous melanoma, primary
`http://id.who.int/icd/release/11/mms`	2C30.Y	Other specified melanoma of skin
`http://id.who.int/icd/release/11/mms`	2C30.Z	Melanoma of skin, unspecified
`http://id.who.int/icd/release/11/mms`	2C31	Squamous cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C31.0	Verrucous squamous cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C31.1	Keratoacanthoma
`http://id.who.int/icd/release/11/mms`	2C31.Z	Cutaneous squamous cell carcinoma
`http://id.who.int/icd/release/11/mms`	2C32	Basal cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C32.0	Nodular basal cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C32.1	Sclerosing basal cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C32.2	Superficial basal cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C32.Y	Other specified basal cell carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C32.Z	Basal cell carcinoma of skin, unspecified
`http://id.who.int/icd/release/11/mms`	2C33	Adnexal carcinoma of skin
`http://id.who.int/icd/release/11/mms`	2C34	Cutaneous neuroendocrine carcinoma
`http://id.who.int/icd/release/11/mms`	2C35	Cutaneous sarcoma
`http://id.who.int/icd/release/11/mms`	2C3Y	Other specified malignant neoplasms of skin
`http://id.who.int/icd/release/11/mms`	2C3Z	Malignant neoplasm of skin of unknown or unspecified type
`http://id.who.int/icd/release/11/mms`	2C40	Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system
`http://id.who.int/icd/release/11/mms`	2C41	Malignant perineurioma
`http://id.who.int/icd/release/11/mms`	2C4Y	Other specified malignant neoplasms of peripheral nerves or autonomic nervous system
`http://id.who.int/icd/release/11/mms`	2C4Z	Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified
`http://id.who.int/icd/release/11/mms`	2C50	Malignant neoplasms of retroperitoneum
`http://id.who.int/icd/release/11/mms`	2C50.0	Cystic, mucinous or serous carcinoma of retroperitoneum
`http://id.who.int/icd/release/11/mms`	2C50.Y	Other specified malignant neoplasms of retroperitoneum
`http://id.who.int/icd/release/11/mms`	2C50.Z	Malignant neoplasms of retroperitoneum, unspecified
`http://id.who.int/icd/release/11/mms`	2C51	Malignant neoplasms of peritoneum
`http://id.who.int/icd/release/11/mms`	2C51.0	Adenocarcinomas of peritoneum
`http://id.who.int/icd/release/11/mms`	2C51.1	Cystic, mucinous or serous carcinoma of peritoneum
`http://id.who.int/icd/release/11/mms`	2C51.2	Mesotheliomas of peritoneum
`http://id.who.int/icd/release/11/mms`	2C51.20	Mesothelioma of mesocolon
`http://id.who.int/icd/release/11/mms`	2C51.21	Mesothelioma of mesentery
`http://id.who.int/icd/release/11/mms`	2C51.2Y	Mesotheliomas of other specified sites of peritoneum
`http://id.who.int/icd/release/11/mms`	2C51.2Z	Mesotheliomas of peritoneum, site unspecified
`http://id.who.int/icd/release/11/mms`	2C51.Y	Other specified malignant neoplasms of peritoneum
`http://id.who.int/icd/release/11/mms`	2C51.Z	Malignant neoplasms of peritoneum, unspecified
`http://id.who.int/icd/release/11/mms`	2C52	Malignant neoplasms of omentum
`http://id.who.int/icd/release/11/mms`	2C52.0	Cystic, mucinous or serous carcinoma of omentum
`http://id.who.int/icd/release/11/mms`	2C52.Y	Other specified malignant neoplasms of omentum
`http://id.who.int/icd/release/11/mms`	2C52.Z	Malignant neoplasms of omentum, unspecified
`http://id.who.int/icd/release/11/mms`	2C53	Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
`http://id.who.int/icd/release/11/mms`	2C53.0	Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum
`http://id.who.int/icd/release/11/mms`	2C53.1	Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum
`http://id.who.int/icd/release/11/mms`	2C53.Y	Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum
`http://id.who.int/icd/release/11/mms`	2C53.Z	Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified
`http://id.who.int/icd/release/11/mms`	2C60	Carcinoma of breast, specialised type
`http://id.who.int/icd/release/11/mms`	2C61	Invasive carcinoma of breast
`http://id.who.int/icd/release/11/mms`	2C61.0	Invasive ductal carcinoma of breast
`http://id.who.int/icd/release/11/mms`	2C61.1	Invasive lobular carcinoma of breast
`http://id.who.int/icd/release/11/mms`	2C61.2	Invasive pleomorphic lobular carcinoma of breast
`http://id.who.int/icd/release/11/mms`	2C61.3	Invasive carcinoma of breast with mixed ductal and lobular features
`http://id.who.int/icd/release/11/mms`	2C61.4	Invasive carcinoma of breast, unidentifiable type
`http://id.who.int/icd/release/11/mms`	2C61.Y	Other invasive carcinoma of breast
`http://id.who.int/icd/release/11/mms`	2C61.Z	Invasive carcinoma of breast, unspecified
`http://id.who.int/icd/release/11/mms`	2C62	Inflammatory carcinoma of breast
`http://id.who.int/icd/release/11/mms`	2C63	Malignant phyllodes tumour of breast
`http://id.who.int/icd/release/11/mms`	2C64	Solid papillary carcinoma of breast with evidence of invasion
`http://id.who.int/icd/release/11/mms`	2C65	Hereditary breast and ovarian cancer syndrome
`http://id.who.int/icd/release/11/mms`	2C6Y	Other specified malignant neoplasms of breast
`http://id.who.int/icd/release/11/mms`	2C6Z	Malignant neoplasms of breast, unspecified
`http://id.who.int/icd/release/11/mms`	2C70	Malignant neoplasms of vulva
`http://id.who.int/icd/release/11/mms`	2C70.0	Basal cell carcinoma of vulva
`http://id.who.int/icd/release/11/mms`	2C70.1	Melanoma of vulva
`http://id.who.int/icd/release/11/mms`	2C70.2	Squamous cell carcinoma of vulva
`http://id.who.int/icd/release/11/mms`	2C70.Y	Other specified malignant neoplasms of vulva
`http://id.who.int/icd/release/11/mms`	2C70.Z	Malignant neoplasms of vulva, unspecified
`http://id.who.int/icd/release/11/mms`	2C71	Malignant neoplasms of vagina
`http://id.who.int/icd/release/11/mms`	2C71.0	Adenocarcinoma of vagina
`http://id.who.int/icd/release/11/mms`	2C71.1	Melanoma of vagina
`http://id.who.int/icd/release/11/mms`	2C71.2	Squamous cell carcinoma of vagina
`http://id.who.int/icd/release/11/mms`	2C71.Y	Other specified malignant neoplasms of vagina
`http://id.who.int/icd/release/11/mms`	2C71.Z	Malignant neoplasms of vagina, unspecified
`http://id.who.int/icd/release/11/mms`	2C72	Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa
`http://id.who.int/icd/release/11/mms`	2C72.0	Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa
`http://id.who.int/icd/release/11/mms`	2C72.1	Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa
`http://id.who.int/icd/release/11/mms`	2C72.3	Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa
`http://id.who.int/icd/release/11/mms`	2C72.Y	Other specified malignant neoplasms of uterine ligament, parametrium, or uterine adnexa
`http://id.who.int/icd/release/11/mms`	2C72.Z	Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified
`http://id.who.int/icd/release/11/mms`	2C73	Malignant neoplasms of ovary
`http://id.who.int/icd/release/11/mms`	2C73.0	Carcinomas of ovary
`http://id.who.int/icd/release/11/mms`	2C73.00	Clear cell adenocarcinoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.01	Endometrioid adenocarcinoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.02	Low grade serous adenocarcinoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.03	High grade serous adenocarcinoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.04	Mucinous adenocarcinoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.0Y	Other specified carcinomas of ovary
`http://id.who.int/icd/release/11/mms`	2C73.0Z	Carcinomas of ovary, unspecified
`http://id.who.int/icd/release/11/mms`	2C73.1	Dysgerminoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.2	Granulosa cell malignant tumour of ovary
`http://id.who.int/icd/release/11/mms`	2C73.3	Malignant teratoma of ovary
`http://id.who.int/icd/release/11/mms`	2C73.4	Serous cystadenoma, borderline malignancy of ovary
`http://id.who.int/icd/release/11/mms`	2C73.5	Endodermal sinus tumour, unspecified site, female
`http://id.who.int/icd/release/11/mms`	2C73.Y	Other specified malignant neoplasms of the ovary
`http://id.who.int/icd/release/11/mms`	2C73.Z	Malignant neoplasms of ovary, unspecified
`http://id.who.int/icd/release/11/mms`	2C74	Malignant neoplasms of fallopian tube
`http://id.who.int/icd/release/11/mms`	2C74.0	Adenocarcinoma of fallopian tube
`http://id.who.int/icd/release/11/mms`	2C74.Y	Other specified malignant neoplasms of fallopian tube
`http://id.who.int/icd/release/11/mms`	2C74.Z	Malignant neoplasms of fallopian tube, unspecified
`http://id.who.int/icd/release/11/mms`	2C75	Malignant neoplasms of placenta
`http://id.who.int/icd/release/11/mms`	2C75.0	Malignant trophoblastic neoplasms of placenta
`http://id.who.int/icd/release/11/mms`	2C75.Y	Other specified malignant neoplasms of placenta
`http://id.who.int/icd/release/11/mms`	2C75.Z	Malignant neoplasms of placenta, unspecified
`http://id.who.int/icd/release/11/mms`	2C76	Malignant neoplasms of corpus uteri
`http://id.who.int/icd/release/11/mms`	2C76.0	Endometrial endometrioid adenocarcinoma
`http://id.who.int/icd/release/11/mms`	2C76.1	Endometrial mucinous adenocarcinoma
`http://id.who.int/icd/release/11/mms`	2C76.2	Endometrial clear cell adenocarcinoma
`http://id.who.int/icd/release/11/mms`	2C76.3	Endometrial serous adenocarcinoma
`http://id.who.int/icd/release/11/mms`	2C76.4	Endometrial mixed adenocarcinoma
`http://id.who.int/icd/release/11/mms`	2C76.40	Endometrial squamous cell carcinoma
`http://id.who.int/icd/release/11/mms`	2C76.41	Endometrial small cell carcinoma
`http://id.who.int/icd/release/11/mms`	2C76.42	Endometrial undifferentiated carcinoma
`http://id.who.int/icd/release/11/mms`	2C76.43	Carcinosarcoma of uterus
`http://id.who.int/icd/release/11/mms`	2C76.4Z	Endometrial mixed adenocarcinoma, unspecified
`http://id.who.int/icd/release/11/mms`	2C76.Y	Other specified malignant neoplasms of corpus uteri
`http://id.who.int/icd/release/11/mms`	2C76.Z	Malignant neoplasms of corpus uteri, unspecified
`http://id.who.int/icd/release/11/mms`	2C77	Malignant neoplasms of cervix uteri
`http://id.who.int/icd/release/11/mms`	2C77.0	Squamous cell carcinoma of cervix uteri
`http://id.who.int/icd/release/11/mms`	2C77.1	Adenocarcinoma of cervix uteri
`http://id.who.int/icd/release/11/mms`	2C77.2	Adenosquamous carcinoma of cervix uteri
`http://id.who.int/icd/release/11/mms`	2C77.3	Neuroendocrine carcinoma of cervix uteri
`http://id.who.int/icd/release/11/mms`	2C77.Y	Other specified malignant neoplasms of cervix uteri
`http://id.who.int/icd/release/11/mms`	2C77.Z	Malignant neoplasms of cervix uteri, unspecified
`http://id.who.int/icd/release/11/mms`	2C78	Malignant neoplasms of uterus, part not specified
`http://id.who.int/icd/release/11/mms`	2C79	Malignant neoplasm involving overlapping sites of female genital organs
`http://id.who.int/icd/release/11/mms`	2C7Y	Other specified malignant neoplasms of female genital organs
`http://id.who.int/icd/release/11/mms`	2C7Z	Malignant neoplasms of female genital organs, unspecified
`http://id.who.int/icd/release/11/mms`	2C80	Malignant neoplasms of testis
`http://id.who.int/icd/release/11/mms`	2C80.2	Germ cell tumour of testis
`http://id.who.int/icd/release/11/mms`	2C80.Y	Other specified malignant neoplasms of testis
`http://id.who.int/icd/release/11/mms`	2C80.Z	Malignant neoplasms of testis, unspecified
`http://id.who.int/icd/release/11/mms`	2C81	Malignant neoplasms of penis
`http://id.who.int/icd/release/11/mms`	2C81.0	Squamous cell carcinoma of penis
`http://id.who.int/icd/release/11/mms`	2C81.1	Melanoma of penis
`http://id.who.int/icd/release/11/mms`	2C81.Y	Other specified malignant neoplasm of penis
`http://id.who.int/icd/release/11/mms`	2C81.Z	Malignant neoplasms of penis, unspecified
`http://id.who.int/icd/release/11/mms`	2C82	Malignant neoplasms of prostate
`http://id.who.int/icd/release/11/mms`	2C82.0	Adenocarcinoma of prostate
`http://id.who.int/icd/release/11/mms`	2C82.Y	Other specified malignant neoplasms of prostate
`http://id.who.int/icd/release/11/mms`	2C82.Z	Malignant neoplasms of prostate, unspecified
`http://id.who.int/icd/release/11/mms`	2C83	Malignant neoplasms of scrotum
`http://id.who.int/icd/release/11/mms`	2C83.0	Squamous cell carcinoma of scrotum
`http://id.who.int/icd/release/11/mms`	2C83.Y	Other specified malignant neoplasms of scrotum
`http://id.who.int/icd/release/11/mms`	2C83.Z	Malignant neoplasms of scrotum, unspecified
`http://id.who.int/icd/release/11/mms`	2C84	Malignant neoplasms of other specified male genital organs
`http://id.who.int/icd/release/11/mms`	2C8Z	Malignant neoplasms of male genital organs, unspecified
`http://id.who.int/icd/release/11/mms`	2C90	Malignant neoplasms of kidney, except renal pelvis
`http://id.who.int/icd/release/11/mms`	2C90.0	Renal cell carcinoma of kidney, except renal pelvis
`http://id.who.int/icd/release/11/mms`	2C90.Y	Other specified malignant neoplasms of kidney, except renal pelvis
`http://id.who.int/icd/release/11/mms`	2C90.Z	Malignant neoplasms of kidney, except renal pelvis, unspecified
`http://id.who.int/icd/release/11/mms`	2C91	Malignant neoplasms of renal pelvis
`http://id.who.int/icd/release/11/mms`	2C91.0	Urothelial carcinoma of renal pelvis
`http://id.who.int/icd/release/11/mms`	2C91.Y	Other specified malignant neoplasms of renal pelvis
`http://id.who.int/icd/release/11/mms`	2C91.Z	Malignant neoplasms of renal pelvis, unspecified
`http://id.who.int/icd/release/11/mms`	2C92	Malignant neoplasms of ureter
`http://id.who.int/icd/release/11/mms`	2C92.0	Urothelial carcinoma of ureter
`http://id.who.int/icd/release/11/mms`	2C92.Y	Other specified malignant neoplasms of ureter
`http://id.who.int/icd/release/11/mms`	2C92.Z	Malignant neoplasms of ureter, unspecified
`http://id.who.int/icd/release/11/mms`	2C93	Malignant neoplasms of urethra or paraurethral gland
`http://id.who.int/icd/release/11/mms`	2C93.0	Adenocarcinoma of urethra or paraurethral gland
`http://id.who.int/icd/release/11/mms`	2C93.1	Squamous cell carcinoma of urethra or paraurethral gland
`http://id.who.int/icd/release/11/mms`	2C93.2	Urothelial carcinoma of urethra or paraurethral gland
`http://id.who.int/icd/release/11/mms`	2C93.Y	Other specified malignant neoplasms of urethra or paraurethral gland
`http://id.who.int/icd/release/11/mms`	2C93.Z	Malignant neoplasms of urethra or paraurethral gland, unspecified
`http://id.who.int/icd/release/11/mms`	2C94	Malignant neoplasms of bladder
`http://id.who.int/icd/release/11/mms`	2C94.0	Adenocarcinoma of urinary bladder
`http://id.who.int/icd/release/11/mms`	2C94.1	Squamous cell carcinoma of urinary bladder
`http://id.who.int/icd/release/11/mms`	2C94.2	Urothelial carcinoma of bladder
`http://id.who.int/icd/release/11/mms`	2C94.Y	Other specified malignant neoplasms of bladder
`http://id.who.int/icd/release/11/mms`	2C94.Z	Malignant neoplasms of bladder, unspecified
`http://id.who.int/icd/release/11/mms`	2C95	Malignant neoplasm involving overlapping sites of urinary organs
`http://id.who.int/icd/release/11/mms`	2C95.0	Adenocarcinoma involving overlapping sites of urinary organs
`http://id.who.int/icd/release/11/mms`	2C95.1	Squamous cell carcinomas involving overlapping sites of urinary organs
`http://id.who.int/icd/release/11/mms`	2C95.2	Urothelial carcinoma involving overlapping sites of urinary organs
`http://id.who.int/icd/release/11/mms`	2C95.Y	Other specified malignant neoplasms of overlapping lesion of urinary organs
`http://id.who.int/icd/release/11/mms`	2C95.Z	Malignant neoplasm involving overlapping sites of urinary organs, unspecified
`http://id.who.int/icd/release/11/mms`	2C9Y	Other specified malignant neoplasms of urinary tract
`http://id.who.int/icd/release/11/mms`	2C9Z	Malignant neoplasms of urinary tract, unspecified
`http://id.who.int/icd/release/11/mms`	2D00	Malignant neoplasm of conjunctiva
`http://id.who.int/icd/release/11/mms`	2D00.0	Melanoma of conjunctiva
`http://id.who.int/icd/release/11/mms`	2D00.1	Malignant neoplasm of caruncle
`http://id.who.int/icd/release/11/mms`	2D00.2	Squamous cell carcinoma of conjunctiva
`http://id.who.int/icd/release/11/mms`	2D00.Y	Other specified malignant neoplasm of conjunctiva
`http://id.who.int/icd/release/11/mms`	2D00.Z	Malignant neoplasm of conjunctiva, unspecified
`http://id.who.int/icd/release/11/mms`	2D01	Malignant neoplasm of cornea
`http://id.who.int/icd/release/11/mms`	2D01.0	Melanoma of cornea
`http://id.who.int/icd/release/11/mms`	2D01.1	Squamous cell carcinoma of cornea
`http://id.who.int/icd/release/11/mms`	2D01.Y	Other specified malignant neoplasms of cornea
`http://id.who.int/icd/release/11/mms`	2D01.Z	Malignant neoplasm of cornea, unspecified
`http://id.who.int/icd/release/11/mms`	2D02	Malignant neoplasm of retina
`http://id.who.int/icd/release/11/mms`	2D02.0	Adenocarcinoma of retinal pigment epithelium
`http://id.who.int/icd/release/11/mms`	2D02.1	Malignant neuroepithelial tumours of retina
`http://id.who.int/icd/release/11/mms`	2D02.2	Retinoblastoma
`http://id.who.int/icd/release/11/mms`	2D02.Y	Other specified malignant neoplasm of retina
`http://id.who.int/icd/release/11/mms`	2D02.Z	Malignant neoplasm of retina, unspecified
`http://id.who.int/icd/release/11/mms`	2D03	Malignant neoplasm of lacrimal apparatus
`http://id.who.int/icd/release/11/mms`	2D03.0	Adenocarcinoma of the lacrimal apparatus
`http://id.who.int/icd/release/11/mms`	2D03.1	Mucoepidermoid carcinoma of lacrimal apparatus
`http://id.who.int/icd/release/11/mms`	2D03.2	Squamous cell carcinoma of the lacrimal apparatus
`http://id.who.int/icd/release/11/mms`	2D03.Y	Other specified malignant neoplasm of lacrimal apparatus
`http://id.who.int/icd/release/11/mms`	2D03.Z	Malignant neoplasm of lacrimal apparatus, unspecified
`http://id.who.int/icd/release/11/mms`	2D04	Malignant neoplasm of orbit
`http://id.who.int/icd/release/11/mms`	2D05	Malignant neoplasm of choroid
`http://id.who.int/icd/release/11/mms`	2D05.0	Melanoma of choroid
`http://id.who.int/icd/release/11/mms`	2D05.Y	Other specified malignant neoplasm of choroid
`http://id.who.int/icd/release/11/mms`	2D05.Z	Malignant neoplasm of choroid, unspecified
`http://id.who.int/icd/release/11/mms`	2D06	Malignant neoplasm of ciliary body
`http://id.who.int/icd/release/11/mms`	2D06.0	Adenocarcinoma of ciliary epithelium
`http://id.who.int/icd/release/11/mms`	2D06.1	Malignant medulloepithelioma of ciliary body
`http://id.who.int/icd/release/11/mms`	2D06.3	Malignant neuroepithelial tumours of ciliary body
`http://id.who.int/icd/release/11/mms`	2D06.4	Melanoma of ciliary body
`http://id.who.int/icd/release/11/mms`	2D06.Y	Other specified malignant neoplasm of ciliary body
`http://id.who.int/icd/release/11/mms`	2D06.Z	Malignant neoplasm of ciliary body, unspecified
`http://id.who.int/icd/release/11/mms`	2D07	Malignant neoplasm of iris
`http://id.who.int/icd/release/11/mms`	2D07.0	Adenocarcinoma of iris epithelium
`http://id.who.int/icd/release/11/mms`	2D07.1	Malignant neuroepithelial tumours of iris
`http://id.who.int/icd/release/11/mms`	2D07.2	Melanoma of iris
`http://id.who.int/icd/release/11/mms`	2D07.Y	Other specified malignant neoplasm of iris
`http://id.who.int/icd/release/11/mms`	2D07.Z	Malignant neoplasm of iris, unspecified
`http://id.who.int/icd/release/11/mms`	2D0Y	Other specified malignant neoplasms of eye or ocular adnexa
`http://id.who.int/icd/release/11/mms`	2D0Z	Malignant neoplasms of eye or ocular adnexa, unspecified
`http://id.who.int/icd/release/11/mms`	2D10	Malignant neoplasms of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.0	Follicular carcinoma of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.1	Papillary carcinoma of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.2	Poorly differentiated carcinoma of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.3	Undifferentiated carcinoma of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.4	Medullary carcinoma of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.Y	Other specified malignant neoplasms of thyroid gland
`http://id.who.int/icd/release/11/mms`	2D10.Z	Malignant neoplasms of thyroid gland, unspecified
`http://id.who.int/icd/release/11/mms`	2D11	Malignant neoplasms of adrenal gland
`http://id.who.int/icd/release/11/mms`	2D11.0	Adenocarcinoma of adrenal gland
`http://id.who.int/icd/release/11/mms`	2D11.1	Malignant phaeochromocytoma of adrenal gland
`http://id.who.int/icd/release/11/mms`	2D11.2	Neuroblastoma of adrenal gland
`http://id.who.int/icd/release/11/mms`	2D11.Y	Other specified malignant neoplasms of adrenal gland
`http://id.who.int/icd/release/11/mms`	2D11.Z	Malignant neoplasms of adrenal gland, unspecified
`http://id.who.int/icd/release/11/mms`	2D12	Malignant neoplasms of other endocrine glands or related structures
`http://id.who.int/icd/release/11/mms`	2D12.0	Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type
`http://id.who.int/icd/release/11/mms`	2D12.1	Adenocarcinoma of other endocrine glands or related structures
`http://id.who.int/icd/release/11/mms`	2D12.Y	Other specified malignant neoplasms of other endocrine glands or related structures
`http://id.who.int/icd/release/11/mms`	2D12.Z	Malignant neoplasms of other endocrine glands or related structures, unspecified
`http://id.who.int/icd/release/11/mms`	2D1Z	Malignant neoplasms of endocrine glands, unspecified
`http://id.who.int/icd/release/11/mms`	2D3Y	Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues
`http://id.who.int/icd/release/11/mms`	2D3Z	Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
`http://id.who.int/icd/release/11/mms`	2D40	Adenocarcinoma of unspecified site
`http://id.who.int/icd/release/11/mms`	2D41	Unspecified carcinoma of unspecified site
`http://id.who.int/icd/release/11/mms`	2D42	Malignant neoplasms of ill-defined sites
`http://id.who.int/icd/release/11/mms`	2D43	Malignant neoplasms of independent, multiple primary sites
`http://id.who.int/icd/release/11/mms`	2D44	Malignant neoplasm, primary site unknown, so stated
`http://id.who.int/icd/release/11/mms`	2D4Y	Other specified malignant neoplasms of unspecified primary sites
`http://id.who.int/icd/release/11/mms`	2D4Z	Unspecified malignant neoplasms of unspecified sites
`http://id.who.int/icd/release/11/mms`	2D50	Malignant neoplasm metastasis in brain
`http://id.who.int/icd/release/11/mms`	2D51	Malignant neoplasm metastasis in meninges
`http://id.who.int/icd/release/11/mms`	2D52	Malignant neoplasm metastasis in spinal cord, cranial nerves or paraspinal nerves
`http://id.who.int/icd/release/11/mms`	2D60	Malignant neoplasm metastasis in lymph node of a single region
`http://id.who.int/icd/release/11/mms`	2D60.0	Malignant neoplasm metastasis in lymph nodes of head, face or neck
`http://id.who.int/icd/release/11/mms`	2D60.1	Malignant neoplasm metastasis in intrathoracic lymph nodes
`http://id.who.int/icd/release/11/mms`	2D60.2	Malignant neoplasm metastasis in intra-abdominal lymph nodes
`http://id.who.int/icd/release/11/mms`	2D60.3	Malignant neoplasm metastasis in axillary lymph nodes
`http://id.who.int/icd/release/11/mms`	2D60.4	Malignant neoplasm metastasis in inguinal lymph nodes
`http://id.who.int/icd/release/11/mms`	2D60.5	Malignant neoplasm metastasis in intrapelvic lymph nodes
`http://id.who.int/icd/release/11/mms`	2D60.Y	Other specified malignant neoplasm metastasis in lymph node of a single region
`http://id.who.int/icd/release/11/mms`	2D60.Z	Malignant neoplasm metastasis in lymph node of a single region, unspecified
`http://id.who.int/icd/release/11/mms`	2D61	Malignant neoplasm metastases in lymph nodes of multiple regions
`http://id.who.int/icd/release/11/mms`	2D6Z	Metastatic malignant neoplasm to unspecified lymph node
`http://id.who.int/icd/release/11/mms`	2D70	Malignant neoplasm metastasis in lung
`http://id.who.int/icd/release/11/mms`	2D71	Malignant neoplasm metastasis in mediastinum
`http://id.who.int/icd/release/11/mms`	2D72	Malignant neoplasm metastasis in pleura
`http://id.who.int/icd/release/11/mms`	2D73	Malignant neoplasm metastasis in upper respiratory tract organs
`http://id.who.int/icd/release/11/mms`	2D7Y	Malignant neoplasm metastasis in other specified thoracic organs
`http://id.who.int/icd/release/11/mms`	2D7Z	Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified
`http://id.who.int/icd/release/11/mms`	2D80	Malignant neoplasm metastasis in liver or intrahepatic bile duct
`http://id.who.int/icd/release/11/mms`	2D80.0	Malignant neoplasm metastasis in liver
`http://id.who.int/icd/release/11/mms`	2D80.1	Malignant neoplasm metastasis in intrahepatic bile duct
`http://id.who.int/icd/release/11/mms`	2D81	Malignant neoplasm metastasis in pancreas
`http://id.who.int/icd/release/11/mms`	2D82	Malignant neoplasm metastasis in extrahepatic bile ducts
`http://id.who.int/icd/release/11/mms`	2D83	Malignant neoplasm metastasis in ampulla of Vater
`http://id.who.int/icd/release/11/mms`	2D84	Malignant neoplasm metastasis in the small intestine
`http://id.who.int/icd/release/11/mms`	2D85	Malignant neoplasm metastasis in large intestine
`http://id.who.int/icd/release/11/mms`	2D86	Malignant neoplasm metastasis in anus
`http://id.who.int/icd/release/11/mms`	2D8Y	Malignant neoplasm metastasis in other specified digestive system organ
`http://id.who.int/icd/release/11/mms`	2D8Z	Malignant neoplasm metastasis in unspecified digestive system organ
`http://id.who.int/icd/release/11/mms`	2D90	Malignant neoplasm metastasis in retroperitoneum
`http://id.who.int/icd/release/11/mms`	2D91	Malignant neoplasm metastasis in peritoneum
`http://id.who.int/icd/release/11/mms`	2E00	Malignant neoplasm metastasis in kidney or renal pelvis
`http://id.who.int/icd/release/11/mms`	2E01	Malignant neoplasm metastasis in bladder
`http://id.who.int/icd/release/11/mms`	2E02	Malignant neoplasm metastasis in other or unspecified urinary system organs
`http://id.who.int/icd/release/11/mms`	2E03	Malignant neoplasm metastasis in bone or bone marrow
`http://id.who.int/icd/release/11/mms`	2E04	Malignant neoplasm metastasis in soft tissue
`http://id.who.int/icd/release/11/mms`	2E05	Malignant neoplasm metastasis in female reproductive system
`http://id.who.int/icd/release/11/mms`	2E05.0	Malignant neoplasm metastasis in ovary
`http://id.who.int/icd/release/11/mms`	2E05.Y	Malignant neoplasm metastasis in other female reproductive system organs
`http://id.who.int/icd/release/11/mms`	2E05.Z	Malignant neoplasm metastasis in female reproductive system, unspecified
`http://id.who.int/icd/release/11/mms`	2E06	Malignant neoplasm metastasis in male genital organs
`http://id.who.int/icd/release/11/mms`	2E07	Malignant neoplasm metastasis in adrenal gland
`http://id.who.int/icd/release/11/mms`	2E08	Malignant neoplasm metastasis in skin
`http://id.who.int/icd/release/11/mms`	2E09	Malignant neoplasm metastasis in peripheral nervous system
`http://id.who.int/icd/release/11/mms`	2E0Y	Malignant neoplasm metastasis in other specified sites
`http://id.who.int/icd/release/11/mms`	2E2Z	Malignant neoplasm metastasis, unspecified
`http://id.who.int/icd/release/11/mms`	2E60	Carcinoma in situ of oral cavity, oesophagus or stomach
`http://id.who.int/icd/release/11/mms`	2E60.0	Carcinoma in situ of lip, oral cavity or pharynx
`http://id.who.int/icd/release/11/mms`	2E60.1	Carcinoma in situ of oesophagus
`http://id.who.int/icd/release/11/mms`	2E60.2	Carcinoma in situ of stomach
`http://id.who.int/icd/release/11/mms`	2E61	Carcinoma in situ of other or unspecified digestive organs
`http://id.who.int/icd/release/11/mms`	2E61.0	Carcinoma in situ of colon
`http://id.who.int/icd/release/11/mms`	2E61.1	Carcinoma in situ of rectum
`http://id.who.int/icd/release/11/mms`	2E61.2	Carcinoma in situ of anal canal
`http://id.who.int/icd/release/11/mms`	2E61.3	Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater
`http://id.who.int/icd/release/11/mms`	2E61.Y	Carcinoma in situ of other specified digestive organs
`http://id.who.int/icd/release/11/mms`	2E61.Z	Carcinoma in situ of unspecified digestive organs
`http://id.who.int/icd/release/11/mms`	2E62	Carcinoma in situ of middle ear or respiratory system
`http://id.who.int/icd/release/11/mms`	2E62.0	Carcinoma in situ of larynx
`http://id.who.int/icd/release/11/mms`	2E62.1	Carcinoma in situ of trachea
`http://id.who.int/icd/release/11/mms`	2E62.2	Carcinoma in situ of bronchus or lung
`http://id.who.int/icd/release/11/mms`	2E62.Y	Carcinoma in situ of other specified sites of middle ear or respiratory system
`http://id.who.int/icd/release/11/mms`	2E62.Z	Carcinoma in situ of unspecified sites of middle ear or respiratory system
`http://id.who.int/icd/release/11/mms`	2E63	Melanoma in situ neoplasms
`http://id.who.int/icd/release/11/mms`	2E63.0	Melanoma in situ of skin
`http://id.who.int/icd/release/11/mms`	2E63.00	Lentigo maligna
`http://id.who.int/icd/release/11/mms`	2E63.0Z	Melanoma in situ of skin, unspecified
`http://id.who.int/icd/release/11/mms`	2E63.1	Melanoma in situ of conjunctiva
`http://id.who.int/icd/release/11/mms`	2E63.Y	Melanoma in situ neoplasms, other specified site
`http://id.who.int/icd/release/11/mms`	2E63.Z	Melanoma in situ neoplasms, unspecified site
`http://id.who.int/icd/release/11/mms`	2E64	Carcinoma in situ of skin
`http://id.who.int/icd/release/11/mms`	2E64.0	Intraepidermal squamous cell carcinoma
`http://id.who.int/icd/release/11/mms`	2E64.00	Bowen disease of skin
`http://id.who.int/icd/release/11/mms`	2E64.01	Actinic intraepidermal squamous cell carcinoma
`http://id.who.int/icd/release/11/mms`	2E64.0Y	Other specified intraepidermal squamous cell carcinoma
`http://id.who.int/icd/release/11/mms`	2E64.0Z	Intraepidermal squamous cell carcinoma, unspecified
`http://id.who.int/icd/release/11/mms`	2E64.1	Extramammary Paget disease of skin
`http://id.who.int/icd/release/11/mms`	2E64.2	Carcinoma in situ of anal margin or perianal skin
`http://id.who.int/icd/release/11/mms`	2E64.Y	Other specified carcinoma in situ of skin
`http://id.who.int/icd/release/11/mms`	2E64.Z	Carcinoma in situ of skin, unspecified
`http://id.who.int/icd/release/11/mms`	2E65	Carcinoma in situ of breast
`http://id.who.int/icd/release/11/mms`	2E65.0	Lobular carcinoma in situ of breast
`http://id.who.int/icd/release/11/mms`	2E65.1	Lobular carcinoma in situ of breast, pleomorphic subtype
`http://id.who.int/icd/release/11/mms`	2E65.2	Ductal carcinoma in situ of breast
`http://id.who.int/icd/release/11/mms`	2E65.3	Ductal carcinoma in situ of breast, comedo subtype
`http://id.who.int/icd/release/11/mms`	2E65.4	Mixed ductal and lobular carcinoma in situ of breast
`http://id.who.int/icd/release/11/mms`	2E65.5	Paget disease of nipple
`http://id.who.int/icd/release/11/mms`	2E65.Y	Other specified carcinoma in situ of breast
`http://id.who.int/icd/release/11/mms`	2E65.Z	Carcinoma in situ of breast, unspecified
`http://id.who.int/icd/release/11/mms`	2E66	Carcinoma in situ of cervix uteri
`http://id.who.int/icd/release/11/mms`	2E66.2	High grade squamous intraepithelial lesion of cervix uteri
`http://id.who.int/icd/release/11/mms`	2E66.Y	Other specified carcinoma in situ of cervix uteri
`http://id.who.int/icd/release/11/mms`	2E66.Z	Carcinoma in situ of cervix uteri, unspecified
`http://id.who.int/icd/release/11/mms`	2E67	Carcinoma in situ of other or unspecified genital organs
`http://id.who.int/icd/release/11/mms`	2E67.0	Carcinoma in situ of endometrium
`http://id.who.int/icd/release/11/mms`	2E67.1	Carcinoma in situ of vulva
`http://id.who.int/icd/release/11/mms`	2E67.11	Vulvar Paget disease
`http://id.who.int/icd/release/11/mms`	2E67.12	Vulvar intraepithelial neoplasia, HPV-independent
`http://id.who.int/icd/release/11/mms`	2E67.13	High grade squamous intraepithelial lesion of vulva, HPV-associated
`http://id.who.int/icd/release/11/mms`	2E67.2	Carcinoma in situ of vagina
`http://id.who.int/icd/release/11/mms`	2E67.22	High grade squamous intraepithelial lesion of vagina
`http://id.who.int/icd/release/11/mms`	2E67.2Y	Other specified carcinoma in situ of vagina
`http://id.who.int/icd/release/11/mms`	2E67.2Z	Carcinoma in situ of vagina, unspecified

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

System

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code